ITGD.F Stock Overview
A healthcare services company, engages in the provision of diagnostic imaging services to general practitioners, medical specialists, and allied health professionals and their patients in Australia and New Zealand. More details
Snowflake Score | |
---|---|
Valuation | 2/6 |
Future Growth | 3/6 |
Past Performance | 0/6 |
Financial Health | 2/6 |
Dividends | 2/6 |
Integral Diagnostics Limited Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | AU$2.10 |
52 Week High | AU$2.10 |
52 Week Low | AU$0.95 |
Beta | 0.75 |
11 Month Change | 0% |
3 Month Change | n/a |
1 Year Change | n/a |
33 Year Change | n/a |
5 Year Change | n/a |
Change since IPO | -4.98% |
Recent News & Updates
Recent updates
Shareholder Returns
ITGD.F | US Healthcare | US Market | |
---|---|---|---|
7D | 0% | 1.6% | 2.2% |
1Y | n/a | 2.1% | 31.7% |
Return vs Industry: Insufficient data to determine how ITGD.F performed against the US Healthcare industry.
Return vs Market: Insufficient data to determine how ITGD.F performed against the US Market.
Price Volatility
ITGD.F volatility | |
---|---|
ITGD.F Average Weekly Movement | n/a |
Healthcare Industry Average Movement | 7.0% |
Market Average Movement | 6.3% |
10% most volatile stocks in US Market | 15.8% |
10% least volatile stocks in US Market | 3.1% |
Stable Share Price: ITGD.F has not had significant price volatility in the past 3 months.
Volatility Over Time: Insufficient data to determine ITGD.F's volatility change over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
1967 | 2,010 | Ian Kadish | www.integraldiagnostics.com.au |
Integral Diagnostics Limited, a healthcare services company, provides diagnostic imaging services to general practitioners, medical specialists, and allied health professionals and their patients in Australia and New Zealand. It provides services through 67 radiology clinics. The company was incorporated in 2008 and is headquartered in Melbourne, Australia.
Integral Diagnostics Limited Fundamentals Summary
ITGD.F fundamental statistics | |
---|---|
Market cap | US$372.17m |
Earnings (TTM) | -US$37.72m |
Revenue (TTM) | US$297.54m |
1.3x
P/S Ratio-9.9x
P/E RatioIs ITGD.F overvalued?
See Fair Value and valuation analysisEarnings & Revenue
ITGD.F income statement (TTM) | |
---|---|
Revenue | AU$456.31m |
Cost of Revenue | AU$307.71m |
Gross Profit | AU$148.60m |
Other Expenses | AU$206.46m |
Earnings | -AU$57.85m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
Aug 27, 2024
Earnings per share (EPS) | -0.25 |
Gross Margin | 32.57% |
Net Profit Margin | -12.68% |
Debt/Equity Ratio | 73.3% |
How did ITGD.F perform over the long term?
See historical performance and comparison